跳至主要内容
临床试验/NCT07256418
NCT07256418招募中不适用

Transcriptomic Study of Cutaneous Fibroblasts in Scleroderma

Centre Hospitalier Universitaire Dijon1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年1月26日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
60
试验地点
1
主要终点
genes involved in the various cell activation and signalling pathways

研究概览

简要总结

Scleroderma is a complex connective tissue disease involving three interconnected pathophysiological axes: vascular hyperactivity and remodelling, immune system dysfunction and over-activation of fibroblasts at the origin of the fibrosis process in the skin and organs. Given that this pathology occurs preferentially in mature subjects, it is possible to suggest a potential inductive role for senescent fibroblasts, which would be responsible for activating and/or maintaining the immune response and systemic inflammation. Our hypothesis is that fibroblasts play a predominant role in the genesis and maintenance of this pathology.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • FOR PATIENTS WITH SCLERODERMA :
  • Person who has given written consent
  • Person with systemic scleroderma
  • FOR CONTROL PARTICIPANTS :
  • Person who has given written consent
  • Person undergoing plastic, cosmetic and reconstructive surgery

排除标准

  • FOR PATIENTS WITH SCLERODERMA :
  • Person not affiliated to or not benefiting from a social security scheme
  • Person subject to a legal protection measure (curatorship, guardianship)
  • Person subject to a legal protection measure
  • An adult who is incapable or unable to give consent
  • FOR CONTROLLED PARTICIPANTS :
  • Person suffering from a chronic disease or under chronic treatment for autoimmune, inflammatory or dermatological diseases
  • Person not affiliated to or not benefiting from a social security scheme
  • Person under legal protection (curatorship, guardianship)
  • Person subject to a legal protection measure
  • An adult who is incapable or unable to give consent

研究组 & 干预措施

Control

People undergoing plastic, cosmetic and reconstructive surgery

干预措施: Analysis of fibroblasts (Other)

Control

People undergoing plastic, cosmetic and reconstructive surgery

干预措施: Skin samples (Procedure)

scleroderma

People with systemic scleroderma

干预措施: Skin samples (Procedure)

scleroderma

People with systemic scleroderma

干预措施: Analysis of fibroblasts (Other)

结局指标

主要结局

genes involved in the various cell activation and signalling pathways

时间窗: through study completion, an average of 12 months

number and type of genes involved in different cell activation and signalling pathways, including senescence, which will be differentially expressed in fibroblasts from the skin of control participants and those from the skin of subjects with SSc.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验